/STRR

STRR Stock - Star Equity Holdings, Inc.

Q: What is the analyst price target for STRR?

Analyst price target information is not currently available for STRR.

Q: What is STRR's market cap?

Market capitalization information is not currently available for STRR.

Healthcare|Medical - Diagnostics & Research|NASDAQ

$10.95+0.18%

+$0.02 (+0.18%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+-26.9%upside

Target: $8.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for STRR

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.49

52W High$14.25

52W Low$8.26

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$53.36M	$161.34M	$112.15M	$106.56M	$78.16M
Gross Profit	$11.05M	$80.27M	$25.88M	$15.24M	$13.99M
Gross Margin	20.7%	49.8%	23.1%	14.3%	17.9%
Operating Income	$-8,415,000	$1.38M	$-3,105,000	$-11,595,000	$-7,208,000
Net Income	$-10,438,000	$2.20M	$-5,252,000	$-2,983,000	$-6,457,000
Net Margin	-19.6%	1.4%	-4.7%	-2.8%	-8.3%
EPS	$-3.97	$-1.11	$-1.27	$-0.96	$-2.29

Company Overview

Star Equity Holdings, Inc. provides healthcare solutions in the United States and internationally. It operates through four segments: Diagnostic Services, Diagnostic Imaging, Construction, and Investments. It offers imaging services primarily to cardiologists, internal medicine physicians, and family practice doctors; and imaging systems, including nuclear cardiac and general purpose nuclear imaging systems to physician offices and hospitals. The company also develops, sells, and maintains solid-state gamma cameras; and provides camera maintenance contract services. In addition, it manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; holds real estate assets; and manages investments. The company was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Old Greenwich, Connecticut.

Visit Website

Earnings History & Surprises

STRR

Beat Rate

40%

Last 20 quarters

Avg Surprise

-340.8%

EPS vs Estimate

Beats / Misses

8/12

Last 12 quarters

Latest EPS

$0.02

Q4 2025

EPS Surprise History

Q1 24

+33.3%

$-0.10vs$-0.15

Q2 24

-350.0%

$-0.45vs$-0.10

Q3 24

-16.0%

$-0.29vs$-0.25

Q4 24

-11.5%

$-0.29vs$-0.26

Q1 25

+188.2%

$0.15vs$-0.17

Q2 25

-108.0%

$-0.52vs$-0.25

Q3 25

-29.4%

$0.12vs$0.17

Q4 25

-93.8%

$0.02vs$0.32

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q4 2025	Nov 13, 2025	$0.32	$0.02	-93.8%	✗ MISS
Q3 2025	Aug 8, 2025	$0.17	$0.12	-29.4%	✗ MISS
Q2 2025	May 14, 2025	$-0.25	$-0.52	-108.0%	✗ MISS
Q1 2025	Mar 20, 2025	$-0.17	$0.15	+188.2%	✓ BEAT
Q4 2024	Nov 19, 2024	$-0.26	$-0.29	-11.5%	✗ MISS
Q3 2024	Aug 13, 2024	$-0.25	$-0.29	-16.0%	✗ MISS
Q2 2024	May 20, 2024	$-0.10	$-0.45	-350.0%	✗ MISS
Q1 2024	Mar 22, 2024	$-0.15	$-0.10	+33.3%	✓ BEAT
Q4 2023	Nov 8, 2023	$-0.30	$0.05	+116.7%	✓ BEAT
Q3 2023	Aug 11, 2023	$0.25	$-0.30	-220.0%	✗ MISS
Q2 2023	May 15, 2023	$-0.28	$0.30	+209.1%	✓ BEAT
Q1 2023	Mar 15, 2023	$-0.10	$0.70	+800.0%	✓ BEAT
Q4 2022	Nov 11, 2022	$-0.35	$0.25	+171.4%	✓ BEAT
Q3 2022	Aug 12, 2022	$0.35	$0.15	-57.1%	✗ MISS
Q2 2022	May 23, 2022	$-0.75	$-0.25	+66.7%	✓ BEAT
Q1 2022	Mar 22, 2022	$0.14	$0.30	+114.3%	✓ BEAT
Q4 2021	Nov 12, 2021	$0.13	$-1.45	-1215.4%	✗ MISS
Q3 2021	Aug 10, 2021	$-0.08	$-3.70	-4525.0%	✗ MISS
Q2 2021	May 14, 2021	$-0.26	$-1.75	-573.1%	✗ MISS
Q1 2021	Mar 9, 2021	$-0.12	$-1.70	-1316.7%	✗ MISS

Frequently Asked Questions about STRR

What is STRR's current stock price?

Star Equity Holdings, Inc. (STRR) is currently trading at $10.95 per share. The stock has moved +0.18% today.

What is the analyst price target for STRR?

The average analyst price target for STRR is $8.00, based on 1 analyst.

What sector is Star Equity Holdings, Inc. in?

Star Equity Holdings, Inc. operates in the Healthcare sector, specifically within the Medical - Diagnostics & Research industry. The company is traded on the NASDAQ exchange.

What is STRR's market cap?

Star Equity Holdings, Inc. has a market capitalization of $0.04 billion, making it a small-cap company.

Does STRR pay dividends?

No, Star Equity Holdings, Inc. does not currently pay a dividend to shareholders.